Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Nisticò R[au]:

Search results

Items: 1 to 50 of 218

1.

Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.

Quattrone A, Morelli M, Quattrone A, Vescio B, Nigro S, Arabia G, Nisticò R, Novellino F, Salsone M, Arcuri P, Luca A, Mazzuca A, Alessio C, Rocca F, Caracciolo M.

Parkinsonism Relat Disord. 2020 Feb 1;72:1-6. doi: 10.1016/j.parkreldis.2020.01.019. [Epub ahead of print]

PMID:
32036297
2.

Reply to the article "Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy".

Capovilla G, Nistico R, Magrelli A.

Epilepsy Behav. 2020 Jan 22:106866. doi: 10.1016/j.yebeh.2019.106866. [Epub ahead of print] No abstract available.

PMID:
31982343
3.

The Innovation Comes from the Sea: Chitosan and Alginate Hybrid Gels and Films as Sustainable Materials for Wastewater Remediation.

Tummino ML, Magnacca G, Cimino D, Laurenti E, Nisticò R.

Int J Mol Sci. 2020 Jan 15;21(2). pii: E550. doi: 10.3390/ijms21020550.

4.

Assessment of the Corticospinal Tract Profile in Pure Lower Motor Neuron Disease: A Diffusion Tensor Imaging Study.

Sarica A, Valentino P, Nisticò R, Barone S, Pucci F, Quattrone A, Cerasa A, Quattrone A.

Neurodegener Dis. 2019 Nov 12:1-11. doi: 10.1159/000503970. [Epub ahead of print]

PMID:
31715609
5.

Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases.

Sheean ME, Malikova E, Duarte D, Capovilla G, Fregonese L, Hofer MP, Magrelli A, Mariz S, Mendez-Hermida F, Nistico R, Leest T, Sipsas NV, Tsigkos S, Vitezic D, Larsson K, Sepodes B, Stoyanova-Beninska V.

Drug Discov Today. 2019 Nov 5. pii: S1359-6446(19)30419-2. doi: 10.1016/j.drudis.2019.10.015. [Epub ahead of print] Review.

6.

Dropped head syndrome in a patient with FTD-ALS caused by abnormal expansion of C9orf72 gene.

Quattrone A, Morelli M, Nisticò R, Manna I, Quattrone A.

Neurol Sci. 2019 Oct 21. doi: 10.1007/s10072-019-04079-9. [Epub ahead of print] No abstract available.

PMID:
31637556
7.

Apomorphine-induced reorganization of striato-frontal connectivity in patients with tremor-dominant Parkinson's disease.

Nigro S, Bordier C, Cerasa A, Nisticò R, Olivadese G, Vescio B, Bianco MG, Fiorillo A, Barbagallo G, Crasà M, Quattrone A, Morelli M, Arabia G, Augimeri A, Nicolini C, Bifone A, Quattrone A.

Parkinsonism Relat Disord. 2019 Oct;67:14-20. doi: 10.1016/j.parkreldis.2019.09.006. Epub 2019 Sep 8.

PMID:
31621599
8.

Targeting Synaptic Plasticity in Experimental Models of Alzheimer's Disease.

Mango D, Saidi A, Cisale GY, Feligioni M, Corbo M, Nisticò R.

Front Pharmacol. 2019 Jul 16;10:778. doi: 10.3389/fphar.2019.00778. eCollection 2019. Review.

9.

Sustainable Magnetic Materials (from Chitosan and Municipal Biowaste) for the Removal of Diclofenac from Water.

Nisticò R, Bianco Prevot A, Magnacca G, Canone L, García-Ballesteros S, Arques A.

Nanomaterials (Basel). 2019 Jul 30;9(8). pii: E1091. doi: 10.3390/nano9081091.

10.

The embodiment of language in tremor-dominant Parkinson's disease patients.

Nisticò R, Cerasa A, Olivadese G, Dalla Volta R, Crasà M, Vasta R, Gramigna V, Vescio B, Barbagallo G, Chiriaco C, Quattrone A, Salsone M, Novellino F, Arabia G, Nicoletti G, Morelli M, Quattrone A.

Brain Cogn. 2019 Oct;135:103586. doi: 10.1016/j.bandc.2019.103586. Epub 2019 Jul 18.

PMID:
31326764
11.

Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system.

Rinaldi L, Delle Donne R, Catalanotti B, Torres-Quesada O, Enzler F, Moraca F, Nisticò R, Chiuso F, Piccinin S, Bachmann V, Lindner HH, Garbi C, Scorziello A, Russo NA, Synofzik M, Stelzl U, Annunziato L, Stefan E, Feliciello A.

Nat Commun. 2019 Jun 12;10(1):2572. doi: 10.1038/s41467-019-10037-y.

12.

Acid-Sensing Ion Channel 1a Is Involved in N-Methyl D-Aspartate Receptor-Dependent Long-Term Depression in the Hippocampus.

Mango D, Nisticò R.

Front Pharmacol. 2019 May 21;10:555. doi: 10.3389/fphar.2019.00555. eCollection 2019.

13.

Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective.

Hampel H, Lista S, Mango D, Nisticò R, Perry G, Avila J, Hernandez F, Geerts H, Vergallo A; Alzheimer Precision Medicine Initiative (APMI).

J Alzheimers Dis. 2019;69(3):615-629. doi: 10.3233/JAD-190197. Review.

PMID:
31156173
14.

The selective disruption of presynaptic JNK2/STX1a interaction reduces NMDA receptor-dependent glutamate release.

Marcelli S, Iannuzzi F, Ficulle E, Mango D, Pieraccini S, Pellegrino S, Corbo M, Sironi M, Pittaluga A, Nisticò R, Feligioni M.

Sci Rep. 2019 May 9;9(1):7146. doi: 10.1038/s41598-019-43709-2.

15.

REM-Sleep Behavior Disorder in Patients With Essential Tremor: What Is Its Clinical Significance?

Salsone M, Arabia G, Manfredini L, Quattrone A, Chiriaco C, Vescio B, Sturniolo M, Morelli M, Nistico' R, Novellino F, Gambardella A, Quattrone A.

Front Neurol. 2019 Apr 24;10:315. doi: 10.3389/fneur.2019.00315. eCollection 2019.

16.

The Effects of Conflict on Fertility: Evidence From the Genocide in Rwanda.

Kraehnert K, Brück T, Di Maio M, Nisticò R.

Demography. 2019 Jun;56(3):935-968. doi: 10.1007/s13524-019-00780-8.

PMID:
31062199
17.

Tips and Tricks for the Surface Engineering of Well-Ordered Morphologically Driven Silver-Based Nanomaterials.

Nisticò R, Rivolo P, Giorgis F.

ChemistryOpen. 2019 Mar 28;8(4):508-519. doi: 10.1002/open.201900007. eCollection 2019 Apr. Review.

18.

The positive allosteric modulator at mGlu2 receptors, LY487379, reverses the effects of chronic stress-induced behavioral maladaptation and synaptic dysfunction in the adulthood.

Mango D, Caruso A, Saidi A, Nisticò R, Scaccianoce S.

Synapse. 2019 Sep;73(9):e22101. doi: 10.1002/syn.22101. Epub 2019 May 23.

PMID:
30964565
19.

Electroacupuncture in rats normalizes the diabetes-induced alterations in the septo-hippocampal cholinergic system.

Protto V, Soligo M, De Stefano ME, Farioli-Vecchioli S, Marlier LNJL, Nisticò R, Manni L.

Hippocampus. 2019 Oct;29(10):891-904. doi: 10.1002/hipo.23088. Epub 2019 Mar 14.

PMID:
30870587
20.

Microstructural changes of normal-appearing white matter in Vascular Parkinsonism.

Salsone M, Caligiuri ME, Vescio V, Arabia G, Cherubini A, Nicoletti G, Morelli M, Quattrone A, Vescio B, Nisticò R, Novellino F, Cascini GL, Sabatini U, Montilla M, Rektor I, Quattrone A.

Parkinsonism Relat Disord. 2019 Jun;63:60-65. doi: 10.1016/j.parkreldis.2019.02.046. Epub 2019 Mar 1.

PMID:
30852150
21.

Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.

Quattrone A, Caligiuri ME, Morelli M, Nigro S, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Vaccaro MG, Sabatini U, Vescio V, Stanà C, Rocca F, Caracciolo M, Quattrone A.

Parkinsonism Relat Disord. 2019 Jun;63:124-130. doi: 10.1016/j.parkreldis.2019.02.022. Epub 2019 Feb 19.

PMID:
30803901
22.

Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study.

Quattrone A, Morelli M, Vescio B, Nigro S, Le Piane E, Sabatini U, Caracciolo M, Vescio V, Quattrone A, Barbagallo G, Stanà C, Nicoletti G, Arabia G, Nisticò R, Novellino F, Salsone M.

Mov Disord. 2019 Apr;34(4):487-495. doi: 10.1002/mds.27621. Epub 2019 Feb 13.

23.

Alzheimer's disease: understanding homeostasis deregulation to foster development of effective therapies.

Nisticò R, Peineau S.

Pharmacol Res. 2019 Jan;139:467-468. doi: 10.1016/j.phrs.2018.12.011. Epub 2018 Dec 13. No abstract available.

PMID:
30553822
24.

Track density imaging in progressive supranuclear palsy: A pilot study.

Nigro S, Bianco MG, Arabia G, Morelli M, Nisticò R, Novellino F, Salsone M, Augimeri A, Quattrone A.

Hum Brain Mapp. 2019 Apr 15;40(6):1729-1737. doi: 10.1002/hbm.24484. Epub 2018 Nov 26.

PMID:
30474903
25.

Optimising bench science to withstand regulatory scrutiny.

Borg JJ, Melchiorri D, Sepodes B, Caramella CM, Tomino C, Micallef B, Serracino-Inglott A, Nistico R.

Pharmacol Res. 2019 Jan;139:491-493. doi: 10.1016/j.phrs.2018.10.014. Epub 2018 Oct 12. No abstract available.

PMID:
30321599
26.

A case of facioscapulohumeral muscular dystrophy and myasthenia gravis with positivity of anti-Ach receptor antibody: a fortuitous association?

Filippelli E, Barone S, Granata A, Nisticò R, Valentino P.

Neurol Sci. 2019 Jan;40(1):195-197. doi: 10.1007/s10072-018-3554-4. Epub 2018 Sep 13. No abstract available.

PMID:
30215155
27.

Block copolymers for designing nanostructured porous coatings.

Nisticò R.

Beilstein J Nanotechnol. 2018 Aug 29;9:2332-2344. doi: 10.3762/bjnano.9.218. eCollection 2018. Review.

28.

A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.

Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Le Piane E, Pugliese P, Bosco D, Vaccaro MG, Chiriaco C, Sabatini U, Vescio V, Stanà C, Rocca F, Gullà D, Caracciolo M.

Parkinsonism Relat Disord. 2018 Sep;54:3-8. doi: 10.1016/j.parkreldis.2018.07.016. Epub 2018 Jul 25.

PMID:
30068492
29.

Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.

Barone S, Caligiuri ME, Valentino P, Cherubini A, Chiriaco C, Granata A, Filippelli E, Tallarico T, Nisticò R, Quattrone A.

J Neurol. 2018 Oct;265(10):2243-2250. doi: 10.1007/s00415-018-8980-y. Epub 2018 Jul 26.

PMID:
30051273
30.

New Insights on the Photodegradation of Caffeine in the Presence of Bio-Based Substances-Magnetic Iron Oxide Hybrid Nanomaterials.

Palma D, Bianco Prevot A, Brigante M, Fabbri D, Magnacca G, Richard C, Mailhot G, Nisticò R.

Materials (Basel). 2018 Jun 26;11(7). pii: E1084. doi: 10.3390/ma11071084.

31.

Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification.

Hampel H, Vergallo A, Giorgi FS, Kim SH, Depypere H, Graziani M, Saidi A, Nisticò R, Lista S; Alzheimer Precision Medicine Initiative (APMI).

Front Neuroendocrinol. 2018 Jul;50:31-51. doi: 10.1016/j.yfrne.2018.06.001. Epub 2018 Jun 12. Review.

PMID:
29902481
32.

Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome.

Arabia G, Lupo A, Manfredini LI, Vescio B, Nisticò R, Barbagallo G, Salsone M, Morelli M, Novellino F, Nicoletti G, Quattrone A, Cascini GL, Louis ED, Quattrone A.

Parkinsonism Relat Disord. 2018 Nov;56:20-26. doi: 10.1016/j.parkreldis.2018.06.005. Epub 2018 Jun 5.

PMID:
29885986
33.

Mutational analysis of TARDBP gene in patients affected by Parkinson's disease from Calabria.

Gagliardi M, Arabia G, Nisticò R, Iannello G, Procopio R, Manfredini L, Annesi G, Quattrone A.

J Neurol Sci. 2018 Jul 15;390:209-211. doi: 10.1016/j.jns.2018.04.043. Epub 2018 May 1.

PMID:
29801890
34.

Midbrain meningioma causing subacute parkinsonism.

Labate A, Nisticò R, Cherubini A, Quattrone A.

Neurol Clin Pract. 2018 Apr;8(2):166-168. doi: 10.1212/CPJ.0000000000000439. No abstract available.

35.

Targeting mGlu5 Metabotropic Glutamate Receptors in the Treatment of Cognitive Dysfunction in a Mouse Model of Phenylketonuria.

Nardecchia F, Orlando R, Iacovelli L, Colamartino M, Fiori E, Leuzzi V, Piccinin S, Nistico R, Puglisi-Allegra S, Di Menna L, Battaglia G, Nicoletti F, Pascucci T.

Front Neurosci. 2018 Mar 16;12:154. doi: 10.3389/fnins.2018.00154. eCollection 2018.

36.

From biowaste to magnet-responsive materials for water remediation from polycyclic aromatic hydrocarbons.

Nisticò R, Cesano F, Franzoso F, Magnacca G, Scarano D, Funes IG, Carlos L, Parolo ME.

Chemosphere. 2018 Jul;202:686-693. doi: 10.1016/j.chemosphere.2018.03.153. Epub 2018 Mar 23.

PMID:
29602101
37.

Role of ASIC1a in Aβ-induced synaptic alterations in the hippocampus.

Mango D, Nisticò R.

Pharmacol Res. 2018 May;131:61-65. doi: 10.1016/j.phrs.2018.03.016. Epub 2018 Mar 21.

PMID:
29574226
38.

Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Hampel H, Toschi N, Babiloni C, Baldacci F, Black KL, Bokde ALW, Bun RS, Cacciola F, Cavedo E, Chiesa PA, Colliot O, Coman CM, Dubois B, Duggento A, Durrleman S, Ferretti MT, George N, Genthon R, Habert MO, Herholz K, Koronyo Y, Koronyo-Hamaoui M, Lamari F, Langevin T, Lehéricy S, Lorenceau J, Neri C, Nisticò R, Nyasse-Messene F, Ritchie C, Rossi S, Santarnecchi E, Sporns O, Verdooner SR, Vergallo A, Villain N, Younesi E, Garaci F, Lista S; Alzheimer Precision Medicine Initiative (APMI).

J Alzheimers Dis. 2018;64(s1):S47-S105. doi: 10.3233/JAD-179932. Review.

39.

The placebo effect on resting tremor in Parkinson's disease: an electrophysiological study.

Barbagallo G, Nisticò R, Vescio B, Cerasa A, Olivadese G, Nigro S, Crasà M, Quattrone A, Bianco MG, Morelli M, Augimeri A, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.

Parkinsonism Relat Disord. 2018 Jul;52:17-23. doi: 10.1016/j.parkreldis.2018.03.012. Epub 2018 Mar 14.

PMID:
29551396
40.

AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy.

Borreca A, Latina V, Corsetti V, Middei S, Piccinin S, Della Valle F, Bussani R, Ammassari-Teule M, Nisticò R, Calissano P, Amadoro G.

Mol Neurobiol. 2018 Oct;55(10):8124-8153. doi: 10.1007/s12035-018-0974-3. Epub 2018 Mar 5.

PMID:
29508283
41.

Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer's disease-like mice overexpressing the human mutant amyloid precursor protein.

Maccarrone M, Totaro A, Leuti A, Giacovazzo G, Scipioni L, Mango D, Coccurello R, Nisticò R, Oddi S.

Pharmacol Res. 2018 Apr;130:366-373. doi: 10.1016/j.phrs.2018.02.009. Epub 2018 Feb 14.

PMID:
29454025
42.

Neuregulin 1/ErbB signalling modulates hippocampal mGluRI-dependent LTD and object recognition memory.

Ledonne A, Mango D, Latagliata EC, Chiacchierini G, Nobili A, Nisticò R, D'Amelio M, Puglisi-Allegra S, Mercuri NB.

Pharmacol Res. 2018 Apr;130:12-24. doi: 10.1016/j.phrs.2018.02.003. Epub 2018 Feb 7.

PMID:
29427771
43.

PDGF Modulates Synaptic Excitability and Short-Latency Afferent Inhibition in Multiple Sclerosis.

Mango D, Nisticò R, Furlan R, Finardi A, Centonze D, Mori F.

Neurochem Res. 2019 Mar;44(3):726-733. doi: 10.1007/s11064-018-2484-0. Epub 2018 Feb 1.

PMID:
29392518
44.

Bromelain Degrades Aβ1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer's Disease Patients.

Sancesario GM, Nuccetelli M, Cerri A, Zegeer J, Severini C, Ciotti MT, Pieri M, Martorana A, Caltagirone C, Nistico R, Bernardini S.

Curr Alzheimer Res. 2018;15(7):628-636. doi: 10.2174/1567205015666180123124851.

PMID:
29359669
45.

Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.

Barbagallo G, Arabia G, Novellino F, Nisticò R, Salsone M, Morelli M, Rocca F, Quattrone A, Caracciolo M, Sabatini U, Cherubini A, Quattrone A.

Parkinsonism Relat Disord. 2018 Feb;47:57-63. doi: 10.1016/j.parkreldis.2017.11.345. Epub 2017 Nov 28.

PMID:
29203059
46.

Sustainable magnet-responsive nanomaterials for the removal of arsenic from contaminated water.

Nisticò R, Celi LR, Bianco Prevot A, Carlos L, Magnacca G, Zanzo E, Martin M.

J Hazard Mater. 2018 Jan 15;342:260-269. doi: 10.1016/j.jhazmat.2017.08.034. Epub 2017 Aug 18.

PMID:
28843795
47.

Recovery of hippocampal functions and modulation of muscarinic response by electroacupuncture in young diabetic rats.

Soligo M, Piccinin S, Protto V, Gelfo F, De Stefano ME, Florenzano F, Berretta E, Petrosini L, Nisticò R, Manni L.

Sci Rep. 2017 Aug 22;7(1):9077. doi: 10.1038/s41598-017-08556-z.

48.

Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study.

Barbagallo G, Arabia G, Morelli M, Nisticò R, Novellino F, Salsone M, Rocca F, Quattrone A, Caracciolo M, Sabatini U, Cherubini A, Quattrone A.

Parkinsonism Relat Disord. 2017 Oct;43:78-84. doi: 10.1016/j.parkreldis.2017.07.028. Epub 2017 Jul 28.

PMID:
28774469
49.

Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study.

Lista S, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Dos Santos AM, Epelbaum S, Lamari F, Dubois B, Nisticò R, Floris R, Garaci F, Hampel H; Alzheimer Precision Medicine Initiative (APMI).

J Alzheimers Dis. 2017;59(4):1327-1334. doi: 10.3233/JAD-170368.

PMID:
28731449
50.

Structural connectivity differences in essential tremor with and without resting tremor.

Caligiuri ME, Arabia G, Barbagallo G, Lupo A, Morelli M, Nisticò R, Novellino F, Quattrone A, Salsone M, Vescio B, Cherubini A, Quattrone A.

J Neurol. 2017 Sep;264(9):1865-1874. doi: 10.1007/s00415-017-8553-5. Epub 2017 Jul 20.

PMID:
28730570

Supplemental Content

Loading ...
Support Center